Unknown

Dataset Information

0

Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival?


ABSTRACT: BACKGROUND: This study aims to provide reasons for the poor sarcoma-related survival in patients with radiation-induced sarcoma (RIS). METHODS: We performed a case-control study comparing sarcoma-related survival of 98 patients with RIS to that of 239 sporadic high-grade malignant sarcomas. RESULTS: The cumulative sarcoma-related 5-year survival was 32% (95% confidence interval (CI): 22-42) for patients with RIS vs 51% (95% CI: 44-58) for controls (P<0.001). Female gender, central tumour site and incomplete surgical remission were significantly more frequent among RIS patients than in controls. In multivariate analysis incomplete surgical remission (hazard ratio (HR) 4.48, 95% CI: 3.08-6.52), metastases at presentation (HR 2.93, 95% CI: 1.95-4.41), microscopic tumour necrosis (HR 1.88, 95% CI: 1.27-2.78) and central tumour site (HR 1.71, 95% CI: 1.18-2.47) remained significant adverse prognostic factors, but not sarcoma category (RIS vs sporadic). CONCLUSION: The poor prognosis of RIS patients are not due to the previous radiotherapy per se, but related to the unfavourable factors - central tumour site, incomplete surgical remission, microscopic tumour necrosis and the presence of metastases, the two former factors overrepresented in RIS.

SUBMITTER: Bjerkehagen B 

PROVIDER: S-EPMC3261679 | biostudies-other | 2012 Jan

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC7916641 | biostudies-literature
2019-06-28 | GSE102055 | GEO
| S-EPMC8718575 | biostudies-literature
| S-EPMC3314285 | biostudies-literature
| S-EPMC4406876 | biostudies-literature
| S-EPMC8427601 | biostudies-literature
| S-EPMC6629293 | biostudies-literature
| S-EPMC6320865 | biostudies-other
| S-EPMC10820332 | biostudies-literature